F. Sato et al., EM574, AN ERYTHROMYCIN DERIVATIVE, IS A MOTILIN RECEPTOR AGONIST IN THE RABBIT, European journal of pharmacology, 322(1), 1997, pp. 63-71
This study was performed to examine whether an erythromycin derivative
, de(N-methyl)-N-isopropyl-8,9-anhydroerythromycin A 6,9-hemiacetal (E
M574) is a motilin receptor agonist in the rabbit gastrointestinal tra
ct. EM574 and porcine motilin induced contractions in segments of isol
ated rabbit intestine with pEC(50) values of 8.26 +/- 0.04 and 8.69 +/
- 0.07, respectively, but not in rat or guinea pig preparations, The s
ensitivity and efficacy of the response to both compounds in rabbits d
ecreased aborally and was insensitive to pretreatment with atropine or
tetrodotoxin, but was markedly suppressed under Ca2+-free conditions.
EM574 and porcine motilin specifically displaced [I-125-Tyr(23)]canin
e motilin bound to gastric antral smooth muscle homogenates with pIC(5
0) values of 8.21 +/- 0.13 and 9.20 +/- 0.11, respectively. The pEC(50
) value for the contractile response and pIC(50) value for the recepto
r binding for motilin, EM574, erythromycin A and three other derivativ
es correlated well (r = 0.94, P < 0.01). Tissue section autoradiograph
y in the antrum revealed that specific labeled motilin binding sites w
ere localized in the circular muscle layer and myenteric plexus, and c
ould be reduced in the presence of an excess of EM574. These results i
ndicate that EM574 is a potent motilin receptor agonist in the rabbit
gastrointestinal tract. (C) 1997 Elsevier Science B.V.